This week we look at a paper published by the U.S. Food and Drug Administration related to artificial intelligence. We also highlight a statement from the World Health Organization declaring that mpox is no longer a global health emergency, a venture fund focused on blood-related research, and an effort ... READ MORE >
Amanda Laskey
Amanda is a senior manager in the tax services practice in the New York City office of RSM US LLP, focusing on clients within the life sciences industry. In addition, she is a member of the firm’s Industry Eminence Program and works alongside RSM’s chief economist and other senior analysts to understand, forecast and communicate economic, business and technology trends affecting middle market businesses. She has nearly 10 years of experience assisting clients with claiming research and development tax credits at both the federal and state levels.